1. Genetic Factors and Hepatitis C Virus Infection
Alexander J. Thompson 
Gastroenterology 
Volume 142, Issue 6, Pages (May 2012)
DOI: /j.gastro
Copyright © 2012 AGA Institute Terms and Conditions

2. Figure 1
Proposed algorithm for the use of IL28B genotyping in the context of telaprevir/boceprevir regimens for treatment-naïve patients. ↑Data for caucasians13; *based on subanalyses of SPRINT-2/RESPOND-231 and ADVANCE29; **patients with advanced fibrosis/cirrhosis may be more suitable for DAA-based therapy; ***patients with advanced fibrosis/cirrhosis may not be suitable for treatment deferral. DAA = direct-acting antiviral; IFN, interferon; pegIFN, peginterferon-α; RBV, ribavirin; RGT, response-guided therapy.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions

3. Gastroenterology 2012 142, 1335-1339DOI: (10. 1053/j. gastro. 2012. 01
Copyright © 2012 AGA Institute Terms and Conditions